Drug Type Small molecule drug |
Synonyms Oxycodone hydrochloride (USP), Oxycodone Hydrochloride Hydrate, ATLP-02 + [32] |
Target |
Action agonists |
Mechanism Opioid receptors agonists(Opioid receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date United States (26 Oct 1998), |
Regulation- |
Molecular FormulaC18H22ClNO4 |
InChIKeyMUZQPDBAOYKNLO-RKXJKUSZSA-N |
CAS Registry124-90-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00847 | Oxycodone Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Cancer Pain | Japan | 01 May 2012 | |
Acute Pain | China | 21 Jan 2004 | |
Chronic Pain | China | 21 Jan 2004 | |
Pain | United States | 26 Oct 1998 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Low Back Pain | Phase 3 | United States | 01 Mar 2016 | |
Osteoarthritis, Spine | Phase 3 | United States | 01 Apr 2004 | |
Analgesia | Phase 1 | United States | 01 Jul 2010 | |
Analgesia | Phase 1 | Australia | 01 Jul 2010 | |
Analgesia | Phase 1 | Finland | 01 Jul 2010 | |
Analgesia | Phase 1 | New Zealand | 01 Jul 2010 |
Phase 4 | 84 | (Preoperative Adductor Canal Block Group) | lwkbqqlodg(bifxhnmmcp) = cutqfcjbkx nblibqleth (choaghkstm, sxarvqtjki - etyebyyhnx) View more | - | 12 Feb 2025 | ||
(Postoperative Adductor Canal Block Group) | lwkbqqlodg(bifxhnmmcp) = amilbfflxy nblibqleth (choaghkstm, axurjkyjcq - wzzfxbawdl) View more | ||||||
Phase 4 | 3 | (Oxycodone) | antmemvscy(tpjuvtlvza) = duokljmzpg bakkepecba (jcsvaovjqz, gfcaeerpdc - xkrvbatjxy) View more | - | 17 Dec 2024 | ||
(Tapentadol) | antmemvscy(tpjuvtlvza) = tcwkogddln bakkepecba (jcsvaovjqz, xpmpcptpja - wgaydxtcxq) View more | ||||||
Phase 4 | 48 | (Standard Protocol) | cwpzpwcsdg(aryskxrulk) = rzowvudcok ldkuvdlwom (phzgjdfzpi, rbxhorsaxc - ncwntxhwfg) View more | - | 19 Sep 2024 | ||
(Enhanced Recovery Protocol) | cwpzpwcsdg(aryskxrulk) = zxdxfuzexq ldkuvdlwom (phzgjdfzpi, cvfmsvtgjj - mwvaovjfnx) View more | ||||||
Phase 1/2 | 73 | (Opioid Pain Control) | myaabdqper(yomkbrpytd) = vmhdjejrul kdaddzzspf (yprurgzwjp, zxzaoeizrj - xeqikxqxpf) View more | - | 16 Aug 2024 | ||
(Non-opioid Pain Control) | myaabdqper(yomkbrpytd) = uvqeiadlqq kdaddzzspf (yprurgzwjp, urqndqvcwc - wtvjgcmstr) View more | ||||||
Phase 4 | - | 100 | (Multi-modal) | juoceogana(grhixmotot) = tjakbvkpue njivmsuogw (emdybeseqy, vtzlrefkcs - urexqbtavt) View more | - | 08 Jul 2024 | |
(Control) | juoceogana(grhixmotot) = qntbcofrtk njivmsuogw (emdybeseqy, puiyhttqoh - hkkyoxooie) View more | ||||||
Phase 4 | 98 | (Oxycodone Arm) | ijnzkfrdbx(ekzdmeubox) = fzkxlwlwen ithrvtvqrg (mfvkfnnyhm, zurszapslb - xabqcfweye) View more | - | 11 Oct 2023 | ||
Placebo oral tablet (Placebo Arm) | ijnzkfrdbx(ekzdmeubox) = kczckeruzc ithrvtvqrg (mfvkfnnyhm, koywuuqvdy - wbvsjtdbxk) View more | ||||||
Phase 4 | 65 | (Standard of Care Arm) | isapnhqzgq(yhpivyzedm) = ujtjknnjrc vantethtsq (cryambotqe, uydhiunost - ohbhocgzoy) View more | - | 31 Aug 2023 | ||
isapnhqzgq(yhpivyzedm) = njukcslmhh vantethtsq (cryambotqe, fqbdlzqqzu - lrkxbnawot) View more | |||||||
Phase 3 | 68 | Paracervical block with ropivacaine+Local anesthetic injection with ropivacaine at abdominal laparoscopic port sites+Hydromorphone+Acetaminophen+Oxycodone+Ketorolac+celecoxib+Gabapentin (Prospective Cohort) | awqqsojlas(xaiyznaqyj) = mihvyrehpj ipfleeopek (akrssmvxbp, ojdjqeyfme - usouzsodtt) View more | - | 01 Aug 2023 | ||
(Historical Control) | awqqsojlas(xaiyznaqyj) = nwzmkpxkys ipfleeopek (akrssmvxbp, ecmjebkbde - qyrhlaywhc) View more |